Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome.
Authors
Kulke, MHörsch, D
Caplin, M
Anthony, L
Bergsland, E
Öberg, K
Welin, S
Warner, R
Lombard-Bohas, C
Kunz, P
Grande, E
Valle, Juan W
Fleming, D
Lapuerta, P
Banks, P
Jackson, S
Zambrowicz, B
Sands, A
Pavel, M
Affiliation
Dana-Farber Cancer Institute, BostonIssue Date
2017-01